Pharmac will undertake a review into its flu vaccine buying system after the country was left with insufficient supplies. It has been in the firing line after the purchase of an under-strength vaccine batch from French company Sanofi Pasteur.
The Ministry of Health and government drug-buying agency Pharmac purchased this year's vaccine through Merck Sharpe and Dohme, but Australian tests later identified the immunisation capability was lacking for one of the three strains of influenza it was designed to protect against.
Source: The New Zeland Herald
Back to Homepage
|
